The immunohistochemical analysis showed the staining intensity of FABP9 was significantly higher in carcinomas than in BPH (Table 1B) and the increased FABP9 stain was significantly correlated with the increased degree of malignancy, as reflected by the increased GS. Here, FABP9 is linked to carcinoma.